KCNS2
Delayed-rectifier potassium channel regulatory subunit KCNS2
Also known as: KCNS2_HUMAN, Kv9.2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULS6
- Gene
- KCNS2
- Ensembl
- ENSG00000156486
- Chromosome
- 8
- Canonical length
- 477 aa
- Protein class
- Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
Predicted to enable potassium channel regulator activity. Predicted to be involved in action potential; potassium ion transmembrane transport; and regulation of potassium ion transmembrane transport. Predicted to be located in perinuclear region of cytoplasm and plasma membrane. Predicted to be part of voltage-gated potassium channel complex. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
477 residues, UniProt reviewed canonical sequence.
>Q9ULS6|KCNS2
1 MTGQSLWDVS EANVEDGEIR INVGGFKRRL RSHTLLRFPE TRLGRLLLCH SREAILELCD
61 DYDDVQREFY FDRNPELFPY VLHFYHTGKL HVMAELCVFS FSQEIEYWGI NEFFIDSCCS
121 YSYHGRKVEP EQEKWDEQSD QESTTSSFDE ILAFYNDASK FDGQPLGNFR RQLWLALDNP
181 GYSVLSRVFS ILSILVVMGS IITMCLNSLP DFQIPDSQGN PGEDPRFEIV EHFGIAWFTF
241 ELVARFAVAP DFLKFFKNAL NLIDLMSIVP FYITLVVNLV VESTPTLANL GRVAQVLRLM
301 RIFRILKLAR HSTGLRSLGA TLKYSYKEVG LLLLYLSVGI SIFSVVAYTI EKEENEGLAT
361 IPACWWWATV SMTTVGYGDV VPGTTAGKLT ASACILAGIL VVVLPITLIF NKFSHFYRRQ
421 KQLESAMRSC DFGDGMKEVP SVNLRDYYAH KVKSLMASLT NMSRSSPSEL SLNDSLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 4 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 4 nTPM
- placenta: 1.4 nTPM
- seminal vesicle: 0.9 nTPM
- amygdala: 0.8 nTPM
- hypothalamus: 0.8 nTPM
- urinary bladder: 0.8 nTPM
Single-cell type
- decidual stromal cells: 8.5 nCPM
- retinal amacrine cells: 4.1 nCPM
- brain inhibitory neurons: 4 nCPM
- brain excitatory neurons: 3.6 nCPM
- endometrial stromal cells: 2.6 nCPM
- other brain neurons: 2.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 21 nTPM
- white matter: 13 nTPM
- basal ganglia: 9.3 nTPM
- spinal cord: 8.6 nTPM
- hypothalamus: 8 nTPM
- amygdala: 6.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.65
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- potassium ion transmembrane transport
- potassium ion transport
- protein homooligomerization
- regulation of potassium ion transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Potassium channel tetramerisation-type BTB domain
- Potassium channel, voltage dependent, Kv
- Potassium channel, voltage dependent, Kv5/Kv9
- Ion transport domain
- SKP1/BTB/POZ domain superfamily
- Voltage-dependent channel domain superfamily
- Voltage-gated potassium channel
- Ion transport protein
- BTB/POZ domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNS2 as an antibody target. Whether an autoantibody or antibody against KCNS2 could matter depends on whether native KCNS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNS2 is annotated at the cell surface, where native KCNS2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...